Skip to main content
. 2019 Jun 1;2019(6):CD004048. doi: 10.1002/14651858.CD004048.pub4

NCT00183443.

Methods A 12‐week, double‐blind, placebo‐controlled ambulatory study
Participants n = 75 with bipolar I disorder with hypomanic, manic, or mixed episodes
Interventions Open‐label divalproex plus adjunctive blinded lithium carbonate, quetiapine or placebo
Outcomes Symptoms of mania, as measured by YMRS (time frame: week 12)
Notes NCT00183443
(study results available January 2019)